热门资讯> 正文
Elicio Therapeutics获得1000万美元融资
2025-06-04 20:03
- Elicio Therapeutics (NASDAQ:ELTX) has entered a $10M senior secured promissory note with existing investor, GKCC.
- The proceeds from the Note Financing, together with Elicio’s current cash and equivalents, are expected to support Elicio’s operations into the first quarter of 2026, beyond the anticipated AMPLIFY-7P Phase 2 interim analysis expected in the third quarter of 2025.
- The Co. received gross proceeds of $10M in the Note Financing.
- The Note bears an interest rate of up to 12.5%, and matures on June 3, 2028, and includes a 24-month interest-only period, and interest accrued during the first 12 months is payable in a lump sum beginning on the thirteenth month after closing.
More on Elicio Therapeutics
- Elicio Therapeutics grants inducement award to new chief strategy and financial officer
- Seeking Alpha’s Quant Rating on Elicio Therapeutics
- Historical earnings data for Elicio Therapeutics
- Financial information for Elicio Therapeutics
推荐文章
一周IPO丨中慧生物暗盘飙涨162%，中签一手赚超4000港元；“减肥药概念”银诺医药招股中
一周财经日历丨重磅财报周！腾讯京东季报轮番登场；美国7月CPI/PPI携手“恐怖数据”来袭
机器人投资风口来袭！世界级盛会催化下，哪些机会不容错过？
美股机会日报丨降息预期骤变！小摩称美联储年内或降息三次；SoundHound飙涨超27%
摩根大通预计美联储将在9月会议上降息25基点，接下来还会连续三次降息
英特尔首席执行官陈立武发文：关于过往职务信息有很多错误 董事会全力支持公司转型工作
美国养老金投资或迎巨变，特朗普颁令为401(k)纳入加密货币等资产铺路
外盘头条：OpenAI发布最强GPT-5；特朗普颁令允许养老金投资另类资产
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
